IWP
VRTX icon

Icon Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Icon Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$868K Sell
2,497
-38
-1% -$13.3K 0.1% 129
2023
Q2 		$892K Sell
2,535
-250
-9% -$84.2K 0.09% 142
2023
Q1 		$877K Buy
+2,785
New +$835K 0.1% 146
2022
Q2 		$896K Sell
3,179
-654
-17% -$175K 0.11% 144
2022
Q1 		$1M Sell
3,833
-966
-20% -$229K 0.1% 151
2021
Q4 		$1.05M Sell
4,799
-141
-3% -$27.4K 0.11% 147
2021
Q3 		$896K Buy
4,940
+1,123
+29% +$219K 0.09% 167
2021
Q2 		$770K Buy
3,817
+137
+4% +$28.7K 0.08% 183
2021
Q1 		$791K Buy
3,680
+788
+27% +$173K 0.1% 161
2020
Q4 		$683K Buy
2,892
+552
+24% +$127K 0.11% 143
2020
Q3 		$637K Sell
2,340
-446
-16% -$123K 0.12% 125
2020
Q2 		$809K Buy
2,786
+1,272
+84% +$345K 0.2% 96
2020
Q1 		$360K Sell
1,514
-139
-8% -$31.9K 0.14% 83
2019
Q4 		$362K Sell
1,653
-202
-11% -$40.9K 0.11% 100
2019
Q3 		$314K Sell
1,855
-10
-0.5% -$1.77K 0.11% 112
2019
Q2 		$342K Buy
1,865
+322
+21% +$56.3K 0.12% 100
2019
Q1 		$284K Sell
1,543
-319
-17% -$58.9K 0.11% 118
2018
Q4 		$309K Sell
1,862
-12
-0.6% -$2.08K 0.15% 99
2018
Q3 		$361K Sell
1,874
-145
-7% -$25.8K 0.15% 107
2018
Q2 		$343K Sell
2,019
-964
-32% -$149K 0.14% 110
2018
Q1 		$486K Sell
2,983
-529
-15% -$86.4K 0.26% 86
2017
Q4 		$526K Buy
+3,512
New +$520K 0.26% 83

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Icon Wealth Partners's VRTX Position: Q3 2023 in Review

Icon Wealth Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 1.5% in Q3 2023, selling an estimated $13.3K and leaving 2,497 shares worth $868K. The position accounts for 0.1% of the portfolio, ranked #129.

Icon Wealth Partners first reported a position in VRTX in Q4 2017 and has held it in 22 quarters since. The position peaked at $1.05M in Q4 2021. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Icon Wealth Partners held 2,497 shares of Vertex Pharmaceuticals worth $868K as of Q3 2023.
  • Icon Wealth Partners sold 38 Vertex Pharmaceuticals shares in Q3 2023, an estimated $13.3K.
  • Vertex Pharmaceuticals made up 0.1% of Icon Wealth Partners's portfolio in Q3 2023, its #129 holding.
  • Icon Wealth Partners first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 22 quarters since.
  • Icon Wealth Partners's Vertex Pharmaceuticals position peaked at $1.05M in Q4 2021.
  • 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.